Thursday, September 15, 2022

FTC Action on Vertical Merger Could Stifle Game-Changing Cancer Technology

FTC Action on Vertical Merger Could Stifle Game-Changing Cancer Technology


Competition Economics Analyst Fred Ashton considers the FTC’s suit to block the merger between Illumina and Grail.

No comments:

Post a Comment